4
A human care company, Elekta pioneers significant innovations and clinical solutions for treating cancer and brain disorders. Elekta provides intelligent and resource-efficient technologies that improve, prolong and save patient lives. We go beyond collaboration seeking long-term relationships built on trust with a shared vision, offering confidence to healthcare providers and their patients. A bold new vision Clarity Soft Tissue Visualization

Clinical Radiotherapy Treatment For Cancer & Brain Disorders - …f890c90a-0d8f-42fc-9075-b... · 2020. 2. 20. · of treatment compound the need for clear soft tissue visualization

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Clinical Radiotherapy Treatment For Cancer & Brain Disorders - …f890c90a-0d8f-42fc-9075-b... · 2020. 2. 20. · of treatment compound the need for clear soft tissue visualization

A human care company, Elekta pioneers significant innovations and clinical solutions for treating

cancer and brain disorders. Elekta provides intelligent and resource-efficient technologies

that improve, prolong and save patient lives. We go beyond collaboration seeking long-term

relationships built on trust with a shared vision, offering confidence to healthcare providers and

their patients.

A bold new vision

Clarity™ Soft Tissue Visualization

Page 2: Clinical Radiotherapy Treatment For Cancer & Brain Disorders - …f890c90a-0d8f-42fc-9075-b... · 2020. 2. 20. · of treatment compound the need for clear soft tissue visualization

CT Clarity™ CT and Clarity fused CT with Clarity contour

Clarity segmented structure

Clarity™

Soft tissue visualization

CT simulation is a key part of radiation

therapy workflows, but its limited soft

tissue visualization can inhibit its ability to

characterize target anatomy and surrounding

structures. Tumor motion and changes in size

and shape of soft tissue targets over the course

of treatment compound the need for clear soft

tissue visualization.

Clarity takes soft tissue visualization to entirely

new levels for Radiation Therapy. Easy to learn

and use, Clarity is capable of integrating with

any External Beam Radiation Therapy workflow

and equipment to support simulation, planning

and treatment.

Support for Simulation and Planning Clarity’s hybrid imaging technology allows clinicians to add superior soft tissue visualization to their existing CT simulation without the extra cost and overhead of a dedicated MRI3.

Clarity hybrid imaging is achieved by acquiring Clarity images at the same time as the CT acquisition procedure with the patient in the same RT setup position. This allows CT and Clarity images to be automatically fused

for seamless integration into simulation and planning workflows1.

Clarity’s patented assisted automated segmentation technology supports clinicians in rapidly contouring and defining 3D soft tissue targets and anatomy prior to treatment planning.

Page 3: Clinical Radiotherapy Treatment For Cancer & Brain Disorders - …f890c90a-0d8f-42fc-9075-b... · 2020. 2. 20. · of treatment compound the need for clear soft tissue visualization

3

Structure-based positioning

Track position, shape and size over time

Add clear soft tissue visualization to simulation, planning and

treatment workflows

Can be added to any existing CT and linac equipment

No imaging dose and no invasive procedures or markers required

Fast image guidance that uses unique and automated, structure- based matching

Affordable hybrid-imaging with automatic fusion to support contouring of soft tissue anatomy

Why Clarity™?

Support for Treatment In the treatment room, Clarity provides clinicians with fast and accurate soft tissue IGRT that can be integrated with any existing external beam delivery workflow, regardless of the platform and without adding any imaging dose.

Clarity uses unique patented segmentation technology to help define and align target structures to the planned daily setup, based on shape, size and position of the anatomy. This provides accurate, structure-based IGRT without the need for surgically implanted markers.

Page 4: Clinical Radiotherapy Treatment For Cancer & Brain Disorders - …f890c90a-0d8f-42fc-9075-b... · 2020. 2. 20. · of treatment compound the need for clear soft tissue visualization

Elekta AB (publ) Box 7593, SE-103 93 Stockholm, Sweden

Tel +46 8 587 254 00 Fax +46 8 587 255 00

[email protected]

Corporate Head Office:

Asia Pacific

Tel +852 2891 2208 Fax +852 2575 7133

[email protected]

www.elekta.com Human Care Makes the Future Possible

North America

Tel +1 770 300 9725 Fax +1 770 448 6338

[email protected]

Regional Sales, Marketing and Service:

Europe, Middle East, Africa, Eastern Europe, Latin America

Tel +46 8 587 254 00 Fax +46 8 587 255 00

[email protected] Art.

nr.

4513

371

091

6 02

:11

©20

11 E

lekt

a AB

(pub

l). A

ll m

enti

oned

trad

emar

ks a

nd r

egis

tere

d tr

adem

arks

are

the

prop

erty

of

the

Elek

ta G

roup

. All

righ

ts r

eser

ved.

No

part

of

this

doc

umen

t may

be

repr

oduc

ed in

any

form

wit

hout

wri

tten

per

mis

sion

from

the

copy

righ

t hol

der.

References

1. F. Dube and T. Sheldon, Accuracy of implicit registration between CT and 3D US in the radiotherapy simulation process, Med. Phys. 35, p. 2683 (2008).

2. T.S. Berrang, P.T. Truong, C. Popescu, L. Drever, H.A. Kader, M.L. Hilts, T. Mitchell, S.Y. Soh, L. Sands, S. Silver and I.A. Olivotto, 3D ultrasound can contribute to planning CT to define the target for partial breast radiotherapy, Int. J. Rad. Onc. Biol. Phys 73, p. 375-383 (2009).

3. G. M. Jacobson, J. Modrick, J. Buechler-Price, V. Betts, M. Muruganandham, J. Bayouth, Comparison of 3D Ultrasound, CT, and MRI for Target Definition in the Post Lumpectomy Breast, Int. J. Rad. Onc. Biol. Phys 78, p. S217 (2010).

InnovationBy providing unique soft tissue hybrid imaging with CT at the time of simulation for automated fusion, contouring soft tissue anatomy can be done with added confidence and consistency2.

EfficiencyUsing patented automated soft tissue segmentation technology, target contouring can be done quickly and easily. Clarity IGRT, based on anatomical structures, means fast patient setup for shorter treatment slots. Easy to learn and use, Clarity is fully integrated into any external beam RT workflow.

FlexibilityClarity offers hybrid imaging and soft tissue IGRT with any CT and linac delivery platform, regardless of age or brand and is compatible with all major TPS systems.

EvidencePersistent 3D imaging and anatomy definition data to allow for monitoring target motion, shape and size over the course of treatment.

ConfidenceClear soft tissue visualization at all stages of external beam RT workflows provides clinicians confidence in anatomy definition for planning and confidence to perform daily treatment shifts.

The Elekta commitment to OncologyElekta product and service development is driven by a commitment

to deliver on five core values in order to offer our customers an

enhanced partnership for the fight against cancer. Clarity

delivers against those values in the following ways: